CBL copy number negatively correlated with KIT protein expression for most tumors; however, seminomas with KIT or KRAS mutations maintained high protein levels of KIT regardless of CBL copies, apparently escaping CBL regulation (Figure S7C). Here, KRAS is linked to seminoma.